FDA Drug recall D-1350-2015
AMPICILLIN CAPSULES, USP, 250 mg, 500 count bottles, Rx only, Manufactured for: DAVA Pharmaceuticals, Inc., Fort Lee, NJ, By: Suir Pharma I…
- FDA Drug
- Class III
- terminated
- Published 2015-08-26
On 2015-08-26 the FDA classified a Class III recall of AMPICILLIN CAPSULES, USP, 250 mg, 500 count bottles, Rx only, Manufactured for: DAVA Pharmaceuticals, Inc., Fort Lee, NJ, By: Suir Pharma I… by Vintage Pharmaceuticals, citing labeling: Incorrect Or Missing Package Insert: Product is labeled with unapproved labeling.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1350-2015 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2015-08-13 |
| Published | 2015-08-26 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Vintage Pharmaceuticals |
| Distribution | OH |
Product
AMPICILLIN CAPSULES, USP, 250 mg, 500 count bottles, Rx only, Manufactured for: DAVA Pharmaceuticals, Inc., Fort Lee, NJ, By: Suir Pharma Ireland Ltd., Clonmel, Ireland, NDC: 67253-180-50
Reason
Labeling: Incorrect Or Missing Package Insert: Product is labeled with unapproved labeling.
Identifiers
| code_info | Lot #: 52217, Expiry: 04/18 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1350-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.